Astral Limited (ASTRAL)
🎯 Key Takeaways
- Astral Limited is in a growth phase driven by strategic capacity expansion and segmental diversification, transitioning from a mature industrial products business to a more vertically integrated player with specialty chemicals ambitions. Management is focused on scaling high-margin CPVC resin production and advancing targeted acquisitions to enhance technological capabilities.
- Revenue grew 1.9% QoQ to ₹1,397 in Q3FY25.
- ⚠️ Margin pressure in the Paints and Adhesives segment, with EBITDA margin declining to 8.7%, poses near-term profitability concerns.
📖 The Story
Astral Limited is in a growth phase driven by strategic capacity expansion and segmental diversification, transitioning from a mature industrial products business to a more vertically integrated player with specialty chemicals ambitions. Management is focused on scaling high-margin CPVC resin production and advancing targeted acquisitions to enhance technological capabilities.
📰 What's Happening
In Q4 FY26, Astral reported consolidated revenue of ₹65,686 million, up 12.6% YoY, with EBITDA margin expanding to 16.9%, supported by 25.1% growth in the Plumbing segment and 40.5% EBITDA growth there. However, Paints and Adhesives saw margin pressure with EBITDA margin declining to 8.7%. The board approved audited results and recommended a final dividend of Rs. 2.50 per share. Additionally, Astral Chemie, a subsidiary, plans to acquire a 60% stake in DSS for ₹39.11 crores to strengthen specialty chemicals capabilities in electronics, aerospace, and renewable energy sectors, with completion targeted by 31 August 2026.
Source: Stock Announcements
📊 Quarterly Results (₹ Cr)
| Metric | Q4FY23 | Q1FY24 | Q2FY24 | Q3FY24 | Q4FY24 | Q1FY25 | Q2FY25 | Q3FY25 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1,506 | 1,283 | 1,363 | 1,370 | 1,625 | 1,384 | 1,370 | 1,397 |
| Operating Profit | 314 | 214 | 234 | 212 | 302 | 226 | 219 | 231 |
| OPM % | 20.5% | 15.7% | 16.1% | 15.0% | 17.9% | 15.5% | 15.3% | 15.7% |
| Net Profit | 206 | 119 | 132 | 113 | 181 | 120 | 109 | 113 |
| EPS | ₹7.66 | ₹4.46 | ₹4.88 | ₹4.23 | ₹6.76 | ₹4.48 | ₹4.10 | ₹4.25 |
Revenue trends show sequential improvement from ₹1,283 crore in Q1FY24 to ₹65,686 million in Q4FY26 (on a consolidated basis), with operating performance stabilizing around 15-17% margins before the latest quarter's margin expansion. PAT margin dipped to 8.1% in Q4FY26 from higher prior levels, reflecting pressure in non-Plumbing segments despite strong volume growth. The company is transitioning from high-growth recovery to scalable profitability, with management citing CPVC plant ramp-up as a catalyst for future margin resilience.
🔮 Management Outlook & What's Next
Management expects full benefits from the new 40,000 M.T. CPVC resin plant to materialize in FY 2027-28, with commercial production scheduled for Q4 2026-27. This capacity is positioned to enhance margins in the Plumbing segment, which already demonstrated 40.5% EBITDA growth. Additionally, the acquisition of DSS is viewed as a strategic enabler for backward integration and expansion into high-growth specialty chemical markets, aligning with long-term margin improvement goals.
Extracted from official company announcements. Not StockFin.ai's opinion.
⚖️ Peer Comparison — Industrial Products
| Company | MCap (₹ Cr) | P/E | ROCE | ROE | D/E |
|---|---|---|---|---|---|
| Cummins India Limited | 1.49 L Cr | 74.4 | — | — | — |
| Polycab India Limited | 1.38 L Cr | 74.8 | — | — | — |
| APL Apollo Tubes Limited | 52,483 | 43.6 | 29.3% | 22.7% | 0.09 |
| KEI Industries Limited | 48,924 | 72.7 | — | — | — |
| Supreme Industries Limited | 44,570 | 43.6 | — | — | — |
| Astral Limited | 41,662 | 79.2 | — | — | — |
| AIA Engineering Limited | 35,987 | 31.0 | 20.4% | 16.8% | 0.07 |
| Welspun Corp Limited | 34,530 | 23.2 | — | — | — |
| Timken India Limited | 26,561 | 61.0 | — | — | — |
| Kirloskar Oil Engines Limited | 25,295 | 49.8 | — | — | — |
🔗 Peer Stock Analyses
⚠️ Risk Factors
1. Margin pressure in the Paints and Adhesives segment, with EBITDA margin declining to 8.7%, poses near-term profitability concerns. 2. Integration risks associated with the proposed acquisition of DSS, including execution timelines and realization of synergies. 3. Execution risk around the CPVC plant ramp-up, with full benefits expected only from FY 2027-28, requiring sustained investment and operational discipline.
📋 Recent Filings
-
🔴 Announcement 11 June 2026Astral Limited announced that its wholly owned subsidiary Astral Chemie Limited will acquire a 60% stake in Differentiated and Sustainable Solutions L...
-
Announcement 3 June 2026Astral Limited announced its participation in the ICICI Securities India Investor Conference 2026, scheduling one-on-one and group meetings with insti...
-
Announcement 2 June 2026Astral Limited announced it will participate in the Citi India Conference 2026 on June 5, 2026, holding one-on-one and group meetings with institution...
-
Announcement 25 May 2026Astral Limited released the transcript of its May 20, 2026 analyst meet on its investor relations website, making it accessible to stakeholders for re...
-
Announcement 20 May 2026Astral Limited announced the availability of a video recording of its May 20, 2026 analyst meet, accessible via a provided web link for institutional ...
-
Announcement 20 May 2026Astral Limited announced its investor presentation for the May 20, 2026 analyst meet, uploading it to its website for stakeholder review. The filing c...
-
🔴 Financial Results 18 May 2026Astral Limited reported consolidated revenue of **₹65,686 million** for Q4 2025-26, up 12.6% YoY, with EBITDA at **₹11,092 million** (16.9% margin), P...
-
🟡 Board Meeting 18 May 2026Astral Limited announced the outcome of its May 18, 2026 board meeting, approving audited financial results for Q4 and FY2026 with an unmodified audit...
-
🔴 Corporate Action 18 May 2026Astral Limited announced a final dividend of Rs. 2.50 per share for FY2026, subject to shareholder approval at the upcoming AGM, alongside the re-appo...
-
🟡 Board Meeting 18 May 2026Astral Limited's board approved audited financial results for Q4 FY2026 ending March 31, 2026, recommending a final dividend of **₹2.50** per share pe...
🧠 Analyst's Read
Astral is executing a multi-year transformation focused on capacity-led growth and strategic diversification into specialty chemicals. Investors should monitor the progress of the CPVC plant commercialization and DSS integration, as these will be critical to sustaining margin momentum and validating the growth narrative.
Based on filing content and financial data. Not a recommendation.
Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-06-16.